Connecting Patients to Clinical Trials

Developing innovative technologies and media for facilitating patient recruitment

TrialX enables...


such as Cinda to find trials for herself and her loved ones

Search Trials


such as Jennifer to complete her clinical trial recruitment on time

Upload Your Trial


such as the Cleveland Clinic to create a centralized trial listing and recruitment tool

Learn More


such as the MMRF to create awareness for research and trials

Learn More

Why customers love TrialX.

Innovative Technology

Developed using an award winning semantic technology that matches patients to trials using their full-clinical record and clinical trial inclusion/exclusion criteria. Recently, we developed another novel interactive question/answering technology (winner of the 2011 NCI/Health 2.0 Developer Challenge) that guides and connects patients to research site using live calls

Great User Experience

At TrialX, we develop tools that we'd like to use. We continually refine the user interface and the flow to make it even easier for our customers to do their tasks effectively.

Customer Service

We Listen. We listen to what our customers say and often we fix/add features even before they tell us. The secret sauce of our awesome customer service is that we also "listen" to DATA. We mine access logs, error logs to solve problems before they arise (sort of like the Minory Report!)

I have been very pleased with the recruitment effort of TrialX for my research studies. They have been very diligent in finding qualified subjects in a reasonable time frame. I would definitely recommend their services to clinical research sites.

Dr. Arthur Waldbaum MD
  • What a fascinating, enlightening conversation!  An hour long broadcast wasn’t enough time to cover Cannabis for Cancer. Dr. Donald I. Abrams is a cancer and integrative medicine specialist at the UCSF Osher Center for Integrative Medicine at Mount Zion. He provides integrative medicine consultations for cancer patients and has completed research in complementary and alternative […]
  • How many different types of multiple myeloma are there?  Six?  Ten or twelve?  According to Dr. Rafael Fonseca, ” Every patient’s myeloma is likely different.” Are you a “high risk” multiple myeloma patient?  Not sure?  Don’t feel bad; myeloma experts can’t seem to agree about what it means.  Monday night’s Cure Talk broadcast guest, Dr. […]
  • Sometimes truth is stranger than fiction.  Pat Killingsworth had a blog post titled, "Can Marijuana and Cialis really kill myeloma cells?" Well it is not fiction, but reality and you can listen to and participate in a Cure Panel talk show featuring  [...]
  • “How am I doing?” I’m often asked; by email, in person or on the phone.  Here’s an update. Dr. Malhotra is now running a SPEP test (measures my M-spike) every two weeks.  This week’s results: I remained at a steady 0.4, same as the last test that had dropped from 0.5 the month before. I’m […]
  • This is a very important broadcast week on Cure Talk Radio.  Monday, our Myeloma Cure Panel will discuss treating high risk multiple myeloma with Mayo Clinic expert Dr. Rafael Fonseca.  Tuesday, I host what should be a fascinating program about using marijuana for cancer patients with Dr. Donald Abrams. Monday’s broadcast is at 6 PM […]
  • We haven’t heard from Tom for over a week.  Here’s his latest email update: Hi Pat, Well, since we last communicated I was able to stay out of hospital for a few days, but I’m back in. I had been having a hard time maintaining a good standing blood pressure (BP). I was faint and […]
  • Dr. Rafael Fonseca Discussed Progress in High Risk Multiple Myeloma on the April Myeloma Cure Panel broadcast.  Dr. Fonseca is the deputy director, Mayo Clinic Cancer Center, Getz Family Professor of Cancer and professor of medicine, Scottsdale, Arizona. To listen to a rebroadcast of the program CLICK HERE. To view a recent summary by P [...]
  • I spent 30 minutes chatting with award winning interviewer, Andrew Schorr at ASH in New Orleans this past December.  I think he saved the best for last. Interested in how I feel after hearing I had relapsed for a third time?  I think Andrew asked just enough questions to get at how I feel about […]
  • Prayer.  I receive dozens of emails each week from readers kind enough to mention that they’re praying for me.  I think it helps!  Knowing I have so many friends supporting me is encouraging. This weekend I received an unusual request.   Take a moment to read this touching email from Denise: Hello Pat- Thank you for […]
  • I’m excited to announce that my publisher has released new and improved versions of my my first two books, Living with Multiple Myeloma and  Stem Cell Transplants from a Patient’s Perspective. Living with Multiple Myeloma describes my emotional and physical struggle with multiple myeloma.  The focus is on how and why I made the fateful […]
  • Watchful waiting is currently the medical standard of care for patients with smoldering myeloma.  2014 could be the year that changes. Myeloma researchers and specialists have been slowly moving in the direction of treating myeloma earlier and more aggressively.  Genetic markers and other indicators are starting to make it easier for doctors to identify high […]
  • Questions about the therapy Dr. Rapoport used to help Patient Snapshot allogeneic stem cell transplant survivor, Mary Jeanne, and others do so well?  Our good friend, Jenny Ahlstrom, recently interviewed him on a mPatient Myeloma Radio broadcast. Here’s a brief explanation about how this exciting new therapy works from the Myeloma Crowd website: Dr. Aaron […]
  • It turns out that Mary Jeanne was part of an enlightening clinical trial.  Allogenic transplants a thing of the past for myeloma patients?  Don’t tell all of the success stories from this study! Here’s a brief look at Mary Jeanne’s experience during and after her transplant: It was a long 26 days, but the care, […]
  • I have been sharing a variety of allogeneic (donor) stem cell transplant stories–both good and bad–these past months.  Mary Jeanne contacted me last week, wanting me to remind our readers that there are allo transplant success stories–and that her’s is one of them: I was diagnosed in Nov. 2010 at Johns Hopkins because the surgeons […]
  • We know that 1 in 5  multiple myeloma patients die in the first 2 months, 1 in 4 in the first year, so what could possibly be the reason?  Usually a MM patient will have symptoms, which will send them to their family doctor.  So why on earth do patients end up going to a hematologist/oncologist with advanced stages of this disease? I do not think that it is lack of insurance, but mostly because the average age is 70 y [...]
  • After re-reading yesterday’s post, something troubled me.  At the end I was practically crowing about outliving the median life expectancy target that my specialist at Mayo Clinic had given me in 2007.  I don’t think that’s right. Yes, we may have some control over how long we live after being diagnosed with multiple myeloma.  But […]
  • Seven years ago today I learned I had cancer.  I’ll Bet you remember exactly when and where you were when you first heard the word, “cancer,” too. I call it, “THE MOMENT.”  I wrote about it in my first book, Living with Multiple Myeloma.  I began writing it ten months after my diagnosis, finishing it […]
  • I wanted to share a variety of myeloma related news with you this morning.  Do you remember my interview of legendary baseball star and Los Angeles Angels hitting coach and multiple myeloma survivor, Don Baylor? Cure Magazine interviews me; plus my on-air interview with Don Baylor   Tuesday Don Baylor broke his femur while reaching […]
  • I participated in a pair of engaging broadcasts recently.  Friday, MD Anderson’s Dr. Robert Orlowski spent over an hour answering questions from our Myeloma Cure Talk panel.  And last night, I spent an hour sharing unvarnished reality with a pair of multiple myeloma survivors on our monthly on-air support group meeting. Dr. Orlowski’s appearance was […]
  • A week ago I promised to pass along more information about MGUS and smoldering multiple myeloma.  I hear from readers with both conditions often.  They are often anxious and stressed about their uncertain futures. I understand!  Learning that you have a chance of developing cancer is a frightening thing.  But after researching MGUS (monoclonal gammopathy […]